HIM
RVPHW

HGC Investment Management’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

HGC Investment Management’s Portfolio RVPHW Stock Details RVPHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-88,700
Closed -$20K – 110
2019
Q3 		$20K Hold
88,700
– – ﹤0.01% 96
2019
Q2 		$18K Buy
+88,700
New +$17.8K ﹤0.01% 90

Other funds holding RVPHW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

HGC Investment Management's RVPHW Position: Q4 2019 in Review

HGC Investment Management sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q4 2019, closing a stake of 88,700 shares — an estimated $20K sold.

HGC Investment Management first reported a position in RVPHW in Q2 2019 and held it in 2 quarters. The position peaked at $20K in Q3 2019. 17 funds tracked by Wall St. Rank hold RVPHW as of Q4 2019.

  • HGC Investment Management reported no remaining Reviva Pharmaceuticals Warrants position as of Q4 2019 after selling out during the quarter.
  • HGC Investment Management sold 88,700 Reviva Pharmaceuticals Warrants shares in Q4 2019, an estimated $20K.
  • HGC Investment Management first reported a position in Reviva Pharmaceuticals Warrants in Q2 2019 and held it in 2 quarters.
  • HGC Investment Management's Reviva Pharmaceuticals Warrants position peaked at $20K in Q3 2019.
  • 17 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q4 2019.

Based on HGC Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.